CLEC-2 expressed on the platelet surface interacts with PDPN expressed on different cell surfaces to mediate diseases such as tumor progression and metastasis, tumor-associated thrombosis, venous thrombosis, arterial thrombosis, and immune diseases. Here, PDPN is linked to neoplasm.